2090-1836

Pulmonary Medicine

Hindawi Limited

View prefix report (10.1155)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 151 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact151 DOIs
2

Add abstracts to 34 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact34 DOIs
3

Deposit reference lists for 14 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact14 DOIs

DOIs for this ISSN

Showing the top 5 of 339 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Radiotherapy for Oligometastases and Oligo-Recurrence of Bon… (10.1155/2012/541656)
Abstract ORCID
84.06 47
2 Oligometastases/Oligo-Recurrence of Lung Cancer (10.1155/2013/438236)
Abstract ORCID
67.12 21
3 Risk Factors for Tuberculosis (10.1155/2013/828939)
ORCID
66.59 460
4 Concave Pattern of a Maximal Expiratory Flow-Volume Curve: A… (10.1155/2012/797495)
Abstract ORCID
63.94 18
5 Clinical Outcomes of Stereotactic Body Radiotherapy for Pati… (10.1155/2012/369820)
Abstract ORCID
62.76 17
6 Inspiratory Capacity during Exercise: Measurement, Analysis,… (10.1155/2013/956081)
ORCID
54.83 155
7 Abdominal Adiposity Correlates with Adenotonsillectomy Outco… (10.1155/2012/351037)
Abstract ORCID
53.96 11
8 Dietary Flaxseed Oil Protects against Bleomycin-Induced Pulm… (10.1155/2012/457031)
Abstract ORCID
53.96 11
9 Novel Insights of Oligometastases and Oligo-Recurrence and R… (10.1155/2012/261096)
ORCID
50.63 105
10 Role of Talc Modulation on Cytokine Activation in Cancer Pat… (10.1155/2012/806183)
Abstract ORCID
50.00 9
11 The Effects of Gas Humidification with High-Flow Nasal Cannu… (10.1155/2012/380686)
ORCID
49.56 95
12 Assessing Exercise Limitation Using Cardiopulmonary Exercise… (10.1155/2012/824091)
ORCID
49.09 91
13 Lung Compliance and Chronic Obstructive Pulmonary Disease (10.1155/2012/542769)
ORCID
48.73 88
14 Interferon-Gamma Release Assays versus Tuberculin Skin Testi… (10.1155/2013/601737)
ORCID
48.73 88
15 Tube Thoracostomy: Complications and Its Management (10.1155/2012/256878)
ORCID
48.24 84
16 Significant Differences in Markers of Oxidant Injury between… (10.1155/2012/301475)
Abstract ORCID
47.71 8
17 Lung Cancer and Interstitial Lung Diseases: A Systematic Rev… (10.1155/2012/315918)
ORCID
46.28 70
18 Erratum to “Practical Guidelines: Lung Transplantation in Pa… (10.1155/2015/698460)
Abstract References ORCID
45.15 3
19 Practical Guidelines: Lung Transplantation in Patients with… (10.1155/2014/621342)
ORCID
44.81 61
20 Long-Term Oxygen Therapy in COPD: Factors Affecting and Ways… (10.1155/2011/325362)
ORCID
44.09 57
21 Expiratory Flow Limitation Definition, Mechanisms, Methods,… (10.1155/2013/749860)
ORCID
43.70 55
22 The Protective Effect of Naringin against Bleomycin-Induced… (10.1155/2016/7601393)
ORCID
43.51 54
23 Adherence with Preventive Medication in Childhood Asthma (10.1155/2011/973849)
ORCID
43.11 52
24 Gradual Increase of High Mobility Group Protein B1 in the Lu… (10.1155/2011/916486)
ORCID
42.69 50
25 Automated Analysis of Crackles in Patients with Interstitial… (10.1155/2011/590506)
ORCID
42.03 47
26 Mechanisms of Physical Activity Limitation in Chronic Lung D… (10.1155/2012/634761)
ORCID
42.03 47
27 Rheumatoid Arthritis-Associated Interstitial Lung Disease: D… (10.1155/2011/872120)
ORCID
41.80 46
28 Responsiveness of Various Exercise-Testing Protocols to Ther… (10.1155/2013/410748)
ORCID
41.57 45
29 Biomarkers to Improve Diagnosis and Monitoring of Obstructiv… (10.1155/2014/930535)
ORCID
41.09 43
30 Exercise Intolerance in Pulmonary Arterial Hypertension (10.1155/2012/359204)
ORCID
40.84 42
31 Postoperative Acute Exacerbation of IPF after Lung Resection… (10.1155/2011/960316)
ORCID
40.58 41
32 The Relationship between Obstructive Sleep Apnea and Atrial… (10.1155/2013/621736)
ORCID
40.58 41
33 Long-Term Chronic Intermittent Hypobaric Hypoxia in Rats Cau… (10.1155/2016/6578578)
ORCID
40.58 41
34 Diffuse Alveolar Damage: A Common Phenomenon in Progressive… (10.1155/2011/531302)
ORCID
40.32 40
35 Intravascular Talcosis due to Intravenous Drug Use Is an Und… (10.1155/2012/617531)
ORCID
40.05 39
36 Cell-Specific Dual Role of Caveolin-1 in Pulmonary Hypertens… (10.1155/2011/573432)
ORCID
39.49 37
37 Ganciclovir Antiviral Therapy in Advanced Idiopathic Pulmona… (10.1155/2011/240805)
ORCID
38.91 35
38 Virus Infection-Induced Bronchial Asthma Exacerbation (10.1155/2012/834826)
ORCID
38.91 35
39 Pathophysiologic Mechanisms of Cardiovascular Disease in Obs… (10.1155/2013/521087)
ORCID
38.91 35
40 Obstructive Sleep Apnea and Coronary Artery Disease: From Pa… (10.1155/2013/768064)
ORCID
38.60 34
41 The Curious Question of Exercise-Induced Pulmonary Edema (10.1155/2011/361931)
ORCID
38.29 33
42 Management Issues for Adolescents with Cystic Fibrosis (10.1155/2012/134132)
ORCID
38.29 33
43 Cigarette-Smoke-Induced Dysregulation of MicroRNA Expression… (10.1155/2012/791234)
ORCID
37.96 32
44 Determination of Best Criteria to Determine Final and Initia… (10.1155/2012/542402)
ORCID
37.63 31
45 Clinical Usefulness of Response Profiles to Rapidly Incremen… (10.1155/2013/359021)
ORCID
37.63 31
46 Quantitative CT: Associations between Emphysema, Airway Wall… (10.1155/2011/419328)
ORCID
37.28 30
47 Clinical Investigation of Benign Asbestos Pleural Effusion (10.1155/2015/416179)
ORCID
37.28 30
48 Accuracy of the Hospital Anxiety and Depression Scale for Id… (10.1155/2014/973858)
ORCID
36.93 29
49 Diagnosis and Management of Pulmonary Arterial Hypertension (10.1155/2011/845864)
ORCID
36.56 28
50 Airway Remodelling in Asthma and COPD: Findings, Similaritie… (10.1155/2012/670414)
ORCID
36.56 28